drugset / Trial / NCT04400487
Actigraphy Improvement With Voxelotor (ActIVe) Study
NaSingle-groupOpen-labelTreatment
Summary
This is a study to evaluate the effect of voxelotor on daily physical activity and sleep quality, as measured by a wrist-worn device in participants with sickle cell disease (SCD) and chronic moderate anemia.
Timeline
- Start
- 2020-12-21
- Primary completion
- 2022-09-08
- Completion
- 2022-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Voxelotor | Small molecule | 1500 mg | Oral |